| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A new classification of interphase nuclei based on spatial organizations of chromosome 8 and 21 for t(8;21) (q22;q22) acute myeloid leukemia by three-dimensional fluorescence in situ hybridization
|
Tian, Xueli
|
|
2015
|
39 |
12 |
p. 1414-1420
7 p.
|
artikel
|
| 2 |
ATP-binding cassette sub-family C member 4 (ABCC4) is overexpressed in human NK/T-cell lymphoma and regulates chemotherapy sensitivity: Potential as a functional therapeutic target
|
Zhang, Xudong
|
|
2015
|
39 |
12 |
p. 1448-1454
7 p.
|
artikel
|
| 3 |
Clinical activity of alvocidib (flavopiridol) in acute myeloid leukemia
|
Zeidner, Joshua F.
|
|
2015
|
39 |
12 |
p. 1312-1318
7 p.
|
artikel
|
| 4 |
Comparison of immune manifestations between refractory cytopenia of childhood and aplastic anemia in children: A single-center retrospective study
|
Wu, Jun
|
|
2015
|
39 |
12 |
p. 1347-1352
6 p.
|
artikel
|
| 5 |
Detectable FLT3-ITD or RAS mutation at the time of transformation from MDS to AML predicts for very poor outcomes
|
Badar, Talha
|
|
2015
|
39 |
12 |
p. 1367-1374
8 p.
|
artikel
|
| 6 |
Editorial board and publication information
|
|
|
2015
|
39 |
12 |
p. IFC-
1 p.
|
artikel
|
| 7 |
Flow cytometric detection of altered signaling in myelodysplastic syndrome and cytopenia
|
Gao, Juehua
|
|
2015
|
39 |
12 |
p. 1396-1404
9 p.
|
artikel
|
| 8 |
FLT3-ITD drives Ara-C resistance in leukemic cells via the induction of RUNX3
|
Damdinsuren, Anar
|
|
2015
|
39 |
12 |
p. 1405-1413
9 p.
|
artikel
|
| 9 |
Hepatitis B seropositivity and risk of developing multiple myeloma or Hodgkin lymphoma: A meta-analysis of observational studies
|
Dalia, Samir
|
|
2015
|
39 |
12 |
p. 1325-1333
9 p.
|
artikel
|
| 10 |
Hope and hype surrounding circulating microRNA as potential next generation AML biomarkers
|
Abdelhamed, Sherif
|
|
2015
|
39 |
12 |
p. 1309-1311
3 p.
|
artikel
|
| 11 |
Impact of telomere length on survival in classic and variant hairy cell leukemia
|
Arons, Evgeny
|
|
2015
|
39 |
12 |
p. 1360-1366
7 p.
|
artikel
|
| 12 |
Increasing aclarubicin dosage of the conventional CAG (low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor) regimen is more efficacious as a salvage therapy than CAG for relapsed/refractory acute myeloid leukemia
|
Qu, Qi
|
|
2015
|
39 |
12 |
p. 1353-1359
7 p.
|
artikel
|
| 13 |
Metformin synergistically sensitizes FLT3-ITD-positive acute myeloid leukemia to sorafenib by promoting mTOR-mediated apoptosis and autophagy
|
Wang, Fangfang
|
|
2015
|
39 |
12 |
p. 1421-1427
7 p.
|
artikel
|
| 14 |
Outcome of myeloablative allogeneic peripheral blood hematopoietic stem cell transplantation for refractory/relapsed AML patients in NR status
|
Liu, Na
|
|
2015
|
39 |
12 |
p. 1375-1381
7 p.
|
artikel
|
| 15 |
Polymorphisms within beta-catenin encoding gene affect multiple myeloma development and treatment
|
Butrym, Aleksandra
|
|
2015
|
39 |
12 |
p. 1462-1466
5 p.
|
artikel
|
| 16 |
Potential role of FLT3-ligand in the angiogenic process of multiple myeloma
|
Kokonozaki, M.
|
|
2015
|
39 |
12 |
p. 1467-1472
6 p.
|
artikel
|
| 17 |
Preserved global histone H4 acetylation linked to ETV6-RUNX1 fusion and PAX5 deletions is associated with favorable outcome in pediatric B-cell progenitor acute lymphoblastic leukemia
|
Janczar, K.
|
|
2015
|
39 |
12 |
p. 1455-1461
7 p.
|
artikel
|
| 18 |
Pyruvate kinase isoform M2 (PKM2) participates in multiple myeloma cell proliferation, adhesion and chemoresistance
|
He, Yunhua
|
|
2015
|
39 |
12 |
p. 1428-1436
9 p.
|
artikel
|
| 19 |
Quantification of EVI1 transcript levels in acute myeloid leukemia by RT-qPCR analysis: A study by the ALFA Group
|
Smol, Thomas
|
|
2015
|
39 |
12 |
p. 1443-1447
5 p.
|
artikel
|
| 20 |
Reconstitution of lymphocyte subpopulations after hematopoietic stem cell transplantation: comparison of hematologic malignancies and donor types in event-free patients
|
Park, Borae G.
|
|
2015
|
39 |
12 |
p. 1334-1341
8 p.
|
artikel
|
| 21 |
Reduced medical costs and hospital days when using oral arsenic plus ATRA as the first-line treatment of acute promyelocytic leukemia
|
Jiang, Hao
|
|
2015
|
39 |
12 |
p. 1319-1324
6 p.
|
artikel
|
| 22 |
Risk of secondary hypogammaglobulinaemia after Rituximab and Fludarabine in indolent non-Hodgkin lymphomas: A retrospective cohort study
|
De Angelis, Federico
|
|
2015
|
39 |
12 |
p. 1382-1388
7 p.
|
artikel
|
| 23 |
Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosis
|
Giri, Smith
|
|
2015
|
39 |
12 |
p. 1342-1346
5 p.
|
artikel
|
| 24 |
Targeting bone marrow lymphoid niches in acute lymphoblastic leukemia
|
Uy, Geoffrey L.
|
|
2015
|
39 |
12 |
p. 1437-1442
6 p.
|
artikel
|
| 25 |
The impact of standard chemotherapy on miRNA signature in plasma in AML patients
|
Koutova, Linda
|
|
2015
|
39 |
12 |
p. 1389-1395
7 p.
|
artikel
|
| 26 |
YM155 suppresses cell proliferation and induces cell death in human adult T-cell leukemia/lymphoma cells
|
Sasaki, Ryousei
|
|
2015
|
39 |
12 |
p. 1473-1479
7 p.
|
artikel
|
Tijdschrift beschrijving